Clinical Trial Update: A Study of the Safety, Tolerance and Assessment of HE3286 on Insulin Sensitivity and Hepatic Glucose Production [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the safety, tolerability, and preliminary effects of HE3286 on insulin sensitivity and hepatic glucose production in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance

Drugs mentioned

• HE3286

Snippet

Sponsor: Harbor Therapeutics | Conditions: Insulin Resistance | Phase 1 | Status: COMPLETED